NCT00700960View on ClinicalTrials.gov

Observational Study Describing Conditions for Administering Slow-acting Insulin Analogue With Oral Antidiabetic Agents in Type 2 Diabetes on Blood Glucose Control

CompletedOBSERVATIONAL
Enrollment

2,745

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
DiabetesDiabetes Mellitus, Type 2
Interventions
DRUG

insulin detemir

initiation of an long acting insulin treatment in association with OAD at the discretion of the physician/diabetologist

Trial Locations (1)

92936

Novo Nordisk Investigational Site, Paris La Défense

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY